Personnel Information

写真a

YAMASAKI Masako


Job title

Assistant Professor
To the head of this page.▲

Campus Career 【 display / non-display 】

  • 2025.04
    -
    Now
    Institute of Science Tokyo， -， Institute of Integrated Research， -， Department of Synthetic Human Body System， Assistant Professor
To the head of this page.▲
 

Published Papers & Misc 【 display / non-display 】

  1. Yoshitaka Nakata, Masako Yamasaki, Yukio Watanabe, Keiya Uriu, Rina Hashimoto, Takuya Yamamoto, , Kei Sato, Akatsuki Saito, Kazuo Takayama. Mpox virus OPG175 negatively regulates viral replication by controlling Wnt signaling. iScience. 2025.12; 28 (12): 114105. ( PubMed, DOI )

  2. Yamasaki M, Saso W, Yamamoto T, Sato M, Takagi H, Hasegawa T, Kozakura Y, Yokoi H, Ohashi H, Tsuchimoto K, Hashimoto R, Fukushi S, Uda A, Muramatsu M, Takayama K, Maeda K, Takahashi Y, Nagase T, Watashi K. Anti-SARS-CoV-2 gapmer antisense oligonucleotides targeting the main protease region of viral RNA. Antiviral research. 2024.10; 230 105992. ( PubMed, DOI )

  3. Ohashi Hirofumi, Nishioka Kazane, Kurihara Tomoki, Nakamura Kou, Yamasaki Masako, Ibayashi Yuuka, Fuchiyama Kanta, Kamo Shogo, Furuyama Yuuki, Ohgane Kenji, Okada Maiko, Kamisuki Shinji, Watashi Koichi, Kuramochi Kouji. ジュグロルビン誘導体の抗C型肝炎ウイルス活性(Anti-hepatitis C Virus Activity of Juglorubin Derivatives) Chemical & Pharmaceutical Bulletin. 2023.11; 71 (11): 843-845. ( ichushi )

  4. Nakamura K, Yamasaki M, Ohashi H, Saito S, Ashikawa K, Sato K, Nishioka K, Suzuki Y, Tsurukawa Y, Kanno K, Mosu N, Murakami H, Nagane M, Okada M, Watashi K, Kamisuki S. Identification of Methylsulochrin as a Partial Agonist for Aryl Hydrocarbon Receptors and Its Antiviral and Anti-inflammatory Activities. Chemical & pharmaceutical bulletin. 2023.08; 71 (8): 650-654. ( PubMed, DOI )

  5. Saso W, Yamasaki M, Nakakita SI, Fukushi S, Tsuchimoto K, Watanabe N, Sriwilaijaroen N, Kanie O, Muramatsu M, Takahashi Y, Matano T, Takeda M, Suzuki Y, Watashi K. Significant role of host sialylated glycans in the infection and spread of severe acute respiratory syndrome coronavirus 2. PLoS pathogens. 2022.06; 18 (6): e1010590. ( PubMed, DOI )

  6. Kobayashi C, Watanabe Y, Oshima M, Hirose T, Yamasaki M, Iwamoto M, Iwatsuki M, Asami Y, Kuramochi K, Wakae K, Aizaki H, Muramatsu M, Sureau C, Sunazuka T, Watashi K. Fungal Secondary Metabolite Exophillic Acid Selectively Inhibits the Entry of Hepatitis B and D Viruses. Viruses. 2022.04; 14 (4): ( PubMed, DOI )

  7. Nishiuchi K, Ohashi H, Nishioka K, Yamasaki M, Furuta M, Mashiko T, Tomoshige S, Ohgane K, Kamisuki S, Watashi K, Kuramochi K. Synthesis and Antiviral Activities of Neoechinulin B and Its Derivatives. Journal of natural products. 2022.01; 85 (1): 284-291. ( PubMed, DOI )

  8. Ohashi H, Wang F, Stappenbeck F, Tsuchimoto K, Kobayashi C, Saso W, Kataoka M, Yamasaki M, Kuramochi K, Muramatsu M, Suzuki T, Sureau C, Takeda M, Wakita T, Parhami F, Watashi K. Identification of Anti-Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Oxysterol Derivatives In Vitro. International journal of molecular sciences. 2021.03; 22 (6): ( PubMed, DOI )

  9. Shionoya K, Yamasaki M, Iwanami S, Ito Y, Fukushi S, Ohashi H, Saso W, Tanaka T, Aoki S, Kuramochi K, Iwami S, Takahashi Y, Suzuki T, Muramatsu M, Takeda M, Wakita T, Watashi K. Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro. Frontiers in microbiology. 2021; 12 651403. ( PubMed, DOI )

▼display all

To the head of this page.▲